Sebi chairperson Tuhin Kanta Pandey highlighted the dual nature of AI in securities market regulation, acknowledging its power for surveillance while warning of risks like opacity and bias. He emphasized the need for regulation to shift from supervising institutions to systems and technology, advocating for anticipatory, resilient markets.
Dr Reddy’s shares slide 7% after delay in semaglutide supplies over quality concerns
Dr Reddy’s shares fell sharply on Thursday after the company delayed commercial supplies of its semaglutide product due to a quality issue involving the active
July 9, 2026